Gara Jalqabaatti › Myelofibrosis
Qorannoo klinikaalii Myelofibrosis Ameerikaa Keessatti hirmaatuu
Qorannoo 56 Myelofibrosis f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 19
- New York City, NYQorannoo 18
- Durham, NCQorannoo 12
- Boston, MAQorannoo 12
- Columbus, OHQorannoo 11
- Seattle, WAQorannoo 11
- Miami, FLQorannoo 10
- Salt Lake City, UTQorannoo 10
- Tampa, FLQorannoo 9
- Nashville, TNQorannoo 9
- Atlanta, GAQorannoo 9
- Cleveland, OHQorannoo 9
- Baldwin Park, CAQorannoo 9
- St. Louis, MOQorannoo 8
- Ann Arbor, MIQorannoo 8
- Chicago, ILQorannoo 7
- Baltimore, MDQorannoo 7
- Birmingham, ALQorannoo 7
- Mountain View, CAQorannoo 7
- Los Angeles, CAQorannoo 6
- Philadelphia, PAQorannoo 6
- Winston-Salem, NCQorannoo 6
- Irvine, CAQorannoo 5
- Kansas City, MOQorannoo 5
- Portland, ORQorannoo 5
- Cincinnati, OHQorannoo 5
- Dallas, TXQorannoo 5
- New Haven, CTQorannoo 4
- Charlotte, NCQorannoo 4
- Milwaukee, WIQorannoo 4
- Denver, COQorannoo 4
- Minneapolis, MNQorannoo 4
- Jacksonville, FLQorannoo 4
- Washington, DCQorannoo 4
- Edison, NJQorannoo 4
- Sacramento, CAQorannoo 3
- The Bronx, NYQorannoo 3
- Coral Springs, FLQorannoo 3
- Orange, CAQorannoo 3
- Charleston, SCQorannoo 3
Naannoon
- AlabamaQorannoo 7
- ArizonaQorannoo 7
- CaliforniaQorannoo 21
- ColoradoQorannoo 6
- ConnecticutQorannoo 5
- FloridaQorannoo 14
- GeorgiaQorannoo 9
- IllinoisQorannoo 7
- KansasQorannoo 6
- MarylandQorannoo 9
- MassachusettsQorannoo 13
- MichiganQorannoo 10
- MinnesotaQorannoo 7
- MissouriQorannoo 8
- New JerseyQorannoo 6
- New YorkQorannoo 21
- North CarolinaQorannoo 17
- OhioQorannoo 17
- OregonQorannoo 6
- PennsylvaniaQorannoo 8
- South CarolinaQorannoo 4
- TennesseeQorannoo 9
- TexasQorannoo 20
- UtahQorannoo 10
- VirginiaQorannoo 5
- WashingtonQorannoo 11
- WisconsinQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04176198A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07357727A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07469891Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07521046A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07623161A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06661915Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06398457Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05320198Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04282187A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06343805High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06345495Pacritinib Effectiveness in Real-world Settings
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07774455A Telehealth Advance Care Planning Intervention
Namoota walitti qabaa jira
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT05875805Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07228624TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07302776A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07008118Quantitative MRI for Myelofibrosis
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT01973881A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT06773195A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07020533Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07250646Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT04370301Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT07128381Allo HSCT Using RIC and PTCy for Hematological Diseases
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 75 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT05805605Registry of Older Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.